Abstract
Cancer is a disease in which abnormal cells divide in an uncontrolled manner and spread to other body parts, which harms normal cells as well. Cancer causes second number of death worldwide after cardiovascular diseases. Depending upon the condition of a patient and the type of cancer, its treatment is now possible with various targeted and nontargeted therapies, due to the evolution in techniques. However, due to some limitations of nontargeted therapies, cancer treatment is now shifted toward targeted therapies, which gives us results with high survival rates of cancer patients. The survival rate of patients mainly depends on the stage of cancer, its detection time, and the therapies used for treatment. Targeted therapies in form of monoclonal antibodies and small molecule inhibitors target only the cancerous cells and provide us with better outcomes of the treatment, also in combination with nontargeted therapies. Nowadays, targeted therapies for almost all types of cancers are being developed and their results provide us with many future opportunities for their use in cancer treatments because of their high efficiency with low levels of toxicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Treatment Landscape of Targeted Therapies in Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
